GLP-3 12mg

Retatrutide (GLP-3)
Retatrutide is a novel tri-agonist peptide that targets three key receptor pathways: GLP-1, GIP, and glucagon receptors. This combination has made it a major subject of interest in research focused on metabolic regulation, energy balance, and appetite signaling.

As a GGG tri-agonist, retatrutide is being explored in both preclinical and clinical settings for its potential to influence energy expenditure, glucose metabolism, and appetite control through both central and peripheral pathways. Studies have highlighted its distinct mechanism of engaging the glucagon receptor to support metabolic output, while also interacting with incretin pathways to modulate satiety and nutrient processing.

Due to its multi-receptor targeting, retatrutide has emerged as a leading compound in the expanding field of metabolic peptide research.